Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Sengenics/OncoREX p53 Cancer Array/35000188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Sengenics/OncoREX p53 Cancer Array/35000

OncoREX p53 Cancer Array

Product Number 35000

Pricing

CodeProduct Description
35000Ap53 Cancer Array Service
35000p53 Cancer Array Kit

Request a Quote

scienceexchange.com

Description

OncoREX™ p53 Cancer Array is a protein array which utilises the patented Sengenics KREX™ functional proteomics technology. All 100 p53 mutant variant proteins on the OncoREX™ p53 Cancer Array are correctly folded and functional as they are expressed as fusion proteins with biotin carboxyl carrier protein (BCCP) which acts as a folding marker and solubility enhancer. The arrays are coated with a proprietary surface which preserves protein folding and inhibits binding of non-specific proteins.

3 key applications of the OncoREX™ p53 cancer array:

1. Discovering new compounds that can restore the function of mutant p532. Direct functional correlation between genotype and phenotype3. Determine the effect of p53 mutations on binding of autoantibodies and antibodies

BROCHURE

APPLICATIONS

Specifications

Product name: OncoREX™ p53 Cancer Array

Minimum Order: 30 slides

Slide Type: Streptavidin-coated glass slide

Species: Human

Storage: Store for up to 12 months at -20°c

Delivery lead time: 4 weeks

Immunome Protein Array Protocol

Protein Array Sample Annotation Form

Protein Array Submission Form

Immunome Protein Array MSDS

Protein List

DOWNLOADS

Resources to access our technology

FAQs

Your technical questions – answered

SOLUTIONS

One technology – endless possibilities

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

© 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361 

新闻动态
行业前沿
技术文章
最新产品